News 07 juin 2023 Genedata expanding its user network The Japanese biopharmaceutical firm Ajinomoto is to use the Genedata solution to accelerate its drug development processes at its site in South K...
Aktuell 07 juin 2023 Genedata weitet Netz seiner Nutzer aus Das japanische Biopharma-Unternehmen Ajinomoto setzt die Lösung von Genedata zur Beschleunigung seiner Medikamentenentwicklung künftig auch an se...
Spotlight 15 juin 2023 Access to Ecosystem Switzerland is a global leader in biotech, medtech and pharma. Find out what makes the Swiss life science industry unique and how your life scien...
Webinar 11 nov 2020 How to enter the Japanese medtech market Japan is the fastest aging society. Its medical device market with an average growth rate of approx. 5% is therefore an interesting export target...
本社 14 juin 2023 製薬、医療技術事業会社の欧州本部 欧州市場への参入を目指す日本のバイオ医薬品企業にとって、スイスは、欧州本部、また欧州・中東・アフリカ事業の地域統括拠点として最適な場所です。地理的なメリット、ビジネスのしやすさ、多様な人材の集積地であることなどが魅力となり、メルクセローノ、武田薬品工業、バイオジェン、ジョンソン・エンド・ジ...
Success stories 25 mai 2023 Yokogawa Innovation Switzerland: How microalgae open up new possibilities for food and medicine. Yokogawa Electric Corporation Microalgae open up new possibilities for food and medicine. From its base in Switzerland, the mission of YIS is to find promising biotechnology f...
News 26 mai 2023 UCB: "It's difficult to beat Swiss quality - even the Chinese admit as much." UCB UCB is a global biopharmaceutical company based in Belgium. Since 1996, it has invested more than 600 million Swiss francs in a state-of-the-art ...